Authors: Smith, Matthew R, Hussain, Maha, Saad, Fred, Fizazi, Karim, Sternberg, Cora N, Crawford, E David, Kopyltsov, Evgeny, Park, Chandler H, Alekseev, Boris, Montesa-Pino, Álvaro, Ye, Dingwei, Parnis, Francis, Cruz, Felipe, Tammela, Teuvo L J, Suzuki, Hiroyoshi, Utriainen, Tapio, Fu, Cheng, Uemura, Motohide, Méndez-Vidal, María J, Maughan, Benjamin L, Joensuu, Heikki, Thiele, Silke, Li, Rui, Kuss, Iris, Tombal, Bertrand, ARASENS Trial Investigators
Subject Terms: Aged, 80 and over, Androgen Antagonists, Androgen Receptor Antagonists, Antineoplastic Agents, Docetaxel, Drug Therapy, Combination, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Neoplasm Metastasis, Neutropenia, Proportional Hazards Models, Prostatic Neoplasms, Castration-Resistant, Pyrazoles
Relation: http://hdl.handle.net/10668/19663; PMC9844551; https://biblio.ugent.be/publication/01GQFQSK145J0MEJJQCRQKK6X9/file/01GRRACNDPT77BXSWKVJ9B6RV6.pdf; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844551/pdf